| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | viral transcription | 3.45e-04 | 58 | 10 | 2 | GO:0019083 | |
| GeneOntologyBiologicalProcess | viral gene expression | 1.21e-03 | 109 | 10 | 2 | GO:0019080 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.51e-03 | 502 | 10 | 3 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.98e-03 | 551 | 10 | 3 | GO:0006397 | |
| Domain | - | 7.14e-03 | 244 | 10 | 2 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 7.95e-03 | 258 | 10 | 2 | IPR012677 | |
| Pubmed | 3.48e-05 | 234 | 10 | 3 | 36243803 | ||
| Pubmed | SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. | 1.58e-04 | 66 | 10 | 2 | 36095012 | |
| Pubmed | Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma. | 1.63e-04 | 67 | 10 | 2 | 29863498 | |
| Cytoband | 1q21.3 | 2.86e-04 | 117 | 10 | 2 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 3.32e-03 | 404 | 10 | 2 | chr1q21 | |
| GeneFamily | RNA binding motif containing | 3.69e-03 | 213 | 8 | 2 | 725 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-04 | 163 | 10 | 2 | 6b11a3ada8725670d0489f404c8c2175ad3904e9 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-04 | 170 | 10 | 2 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.94e-04 | 179 | 10 | 2 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-04 | 186 | 10 | 2 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.73e-04 | 189 | 10 | 2 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.73e-04 | 189 | 10 | 2 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.73e-04 | 189 | 10 | 2 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-04 | 190 | 10 | 2 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.81e-04 | 190 | 10 | 2 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-04 | 190 | 10 | 2 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.89e-04 | 191 | 10 | 2 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.97e-04 | 192 | 10 | 2 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-04 | 193 | 10 | 2 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.05e-04 | 193 | 10 | 2 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.05e-04 | 193 | 10 | 2 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | facs-Lung-nan-3m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.22e-04 | 195 | 10 | 2 | 7f9b7f15006610ad591063d90e90367bd6083c7f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.30e-04 | 196 | 10 | 2 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.39e-04 | 197 | 10 | 2 | 3f088eb29197bc575400d6dafd8083e69e4a149f | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 8.39e-04 | 197 | 10 | 2 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.39e-04 | 197 | 10 | 2 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.39e-04 | 197 | 10 | 2 | 965d5a3f8c9b12cb8a8d3429702ae29ebd8c6122 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 8.39e-04 | 197 | 10 | 2 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 8.47e-04 | 198 | 10 | 2 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.47e-04 | 198 | 10 | 2 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.56e-04 | 199 | 10 | 2 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 8.56e-04 | 199 | 10 | 2 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 8.64e-04 | 200 | 10 | 2 | 792fef1f3e47ce5c131fedfad55075fc254aeead | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 8.64e-04 | 200 | 10 | 2 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| Drug | TRAM-34 | 1.55e-04 | 43 | 10 | 2 | CID000656734 | |
| Drug | Iron, Dietary | 1.78e-04 | 46 | 10 | 2 | ctd:D019266 | |
| Drug | MP-B | 5.94e-04 | 84 | 10 | 2 | CID000016827 | |
| Drug | DB08184 | 2.32e-03 | 167 | 10 | 2 | CID009547945 | |
| Drug | silver nanoparticles | 2.45e-03 | 172 | 10 | 2 | CID000023954 | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 2.80e-03 | 184 | 10 | 2 | 4430_DN | |
| Drug | fullerene C60 | 2.84e-03 | 1498 | 10 | 4 | ctd:C069837 | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 2231_UP | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 1706_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 2634_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA | 3.04e-03 | 192 | 10 | 2 | 1047_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 4219_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.11e-03 | 194 | 10 | 2 | 1073_UP | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 4662_DN | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 4429_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 7221_DN | |
| Disease | age-related macular degeneration | 3.98e-04 | 89 | 10 | 2 | EFO_0001365 | |
| Disease | FEV/FEC ratio | 5.12e-04 | 1228 | 10 | 4 | EFO_0004713 | |
| Disease | sexual dimorphism measurement | 5.17e-03 | 1106 | 10 | 3 | EFO_0021796 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSDLFGDMDGAHGA | 461 | Q8N6H7 | |
| MASSGGELGSLFDHH | 1 | Q5RL73 | |
| DNMSEGSDDSGLHGA | 1021 | Q13127 | |
| GSGHSESSDSEVHSG | 1421 | Q5D862 | |
| MHGHGGYDSDFSDDE | 1 | Q70Z53 | |
| MDTSGHFHDSGVGDL | 1 | Q9UGI6 | |
| SDSDSDSGFTHGHMG | 786 | Q14432 | |
| TTSASHSHGGGDSSM | 26 | O15431 | |
| DGFSGHVGNHGHSME | 496 | P14373 | |
| VHSSGSSDAHMDASG | 21 | O15042 |